Cell-Mediated Immune Responses to Human Papillomavirus 16 E6 and E7 Antigens as Measured by Interferon Gamma Enzyme-Linked Immunospot in Women With Cleared or Persistent Human Papillomavirus Infection
Open Access
- 1 April 2009
- journal article
- research article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 19 (4) , 508-512
- https://doi.org/10.1111/igc.0b013e3181a388c4
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Vaccination trial with HPV16 L1E7 chimeric virus‐like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3)International Journal of Cancer, 2007
- Anti-cancer activity of plant-produced HPV16 E7 vaccineVaccine, 2007
- Human papillomavirus type 16 E2- and L1-specific serological and T-cell responses in women with vulval intraepithelial neoplasiaJournal of General Virology, 2003
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Serum Immunoglobulin G Response to Human Papillomavirus Type 16 Virus‐Like Particles in Human Immunodeficiency Virus (HIV)–Positive and Risk‐Matched HIV‐Negative WomenThe Journal of Infectious Diseases, 2003
- A population‐based prospective study of Chlamydia trachomatis infection and cervical carcinomaInternational Journal of Cancer, 2002
- Cell-Mediated Immune Response to Human Papillomavirus InfectionClinical and Diagnostic Laboratory Immunology, 2001
- Persistence of Human Papillomavirus Type 16 Infection Is Associated with Lack of Cytotoxic T Lymphocyte Response to the E6 AntigensThe Journal of Infectious Diseases, 2000
- Detection Of High-Risk Human Papillomavirus In The Cervix And Semen Of Sex PartnersThe Journal of Infectious Diseases, 1994
- Detection of Papillomavirus DNA in Human SemenScience, 1986